Immunogenicity

-

SMi is launching its inaugural Immunogenicity Conference, taking place in London on the 14th and 15th July. This two day event is designed to enhance SMi’s portfolio of pharmaceutical conferences, especially with a growing demand for biologic therapeutics.

We ask the questions: What stimulates an immune response? How does the system cope with immunogenic compounds? And how do you screen for potential problems?

The Conference will address all these concerns and enable Clinical Immunologists, Physicians and Specialists within the field of Immunogenicity to discuss the major challenges currently being faced within the pharmaceutical industry.

The focus is on pre-clinical analysis and assessing treatments for clinical development. It will endeavour to look at the assessment of early risks in immunogenicity and the evaluation of in silico tools for determining immunogenicity. With an insight into the safety, development and validation of Monoclonal Antibodies.

Immunogenicity is a hurdle one looks to overcome and with the likes of aggregation being a factor when handling proteins, key sessions on Immunomodulation and Inducing Immunological Tolerance will enable delegates to get an understanding of how to address this and improve probability and efficacy.

From a clinical perspective, the conference will assess consideration and design of biologic therapeutics, clinical implications and review what the clinical outcomes are from using these immune modulatory approaches.

The conference will also look at, how to benefit the patient by assessing efficacy and toxicological concerns alongside the management of immunogenic responses. With regulators supposing that animal studies are not good predictors – how can predictability be shown with pre-clinical in-vitro tools?

Business Benefits:
•Grasp an understanding of Immunogenicity and gain an insight into assessing early risks
•Hear case studies on the tools for consideration being utilised for the determination of immunogenicity
•Assess major hurdles in clinical development and the implications in design of biologic therapeutics
•Enhance your understanding on how to best evaluate read outs for immune response
Conference Chairs:
•Matthew Baker, Chief Scientific Officer, Antitope
•Martin Lechmann,Development DMPK Project Leader, Roche
Key Speakers include:
•Robert Dodge, Associate Director, BMS
•Thomas Lee, Scientific Investigator, Clinical Immunology, GSK
•Ronit Mazor, Research Fellow, National Cancer Institute,National Institutes of Health
•Anne De Groot, CEO/CSO, EpiVax Inc
•Daniel Kramer, Associate Director, Project Representative NBE, Merck Serono
•Takashi Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences Inc.



PLUS TWO INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOPS
A: Clinical Impact of Immunogenicity and Predictive Tools, Workshop Leader: Melody Sauerborn, Senior Expert Immunogenicity, TNO Triskelion
B: Immunogenicity of Biosimilars, Workshop Leader: John Chappell, Head of Immunoassay, CPR Pharma Services

For more information click on the event website link or contact Fateja Begum on +44 (0) 20 7827 6184 or email fbegum@smi-online.co.uk


Location:
Holiday Inn Regents Park
London
UK


Organizer: SMi Group Ltd

14 Jul 2014



All Upcoming Events
1 2 Next 
Pain Medicine 201719 Oct 2017
International Conference on Biotech Pharmaceuticals23 Oct 2017
Powering Precision Health Summit 201724 Oct 2017
CYTO ASIA 201725 Oct 2017
Macrophage Biology in the Single-Cell Era26 Oct 2017
Preclinical Development Operations Summit 201731 Oct 2017
4th Drug Discovery Innovation Programme2 Nov 2017
Plant Genomics & Gene Editing Congress: USA2 Nov 2017
Partnerships in Biocontrol, Biostimulants & Microbiome Congress2 Nov 2017
BioData World Congress 20172 Nov 2017
5th Microbiome R&D and Business Collaboration Forum: USA2 Nov 2017
The 2nd Probiotics Congress: USA2 Nov 2017
Recent Advances in Food Analysis (RAFA 2017)7 Nov 2017
Commercialization in China, Japan & Korea - Myths, Misconceptions & Possibilities9 Nov 2017
Commercialization in China, Japan & Korea - Myths, Misconceptions & Possibilities10 Nov 2017
Neuroscience 201711 Nov 2017
Superbugs & Superdrugs USA13 Nov 2017
Pharmaceutical Microbiology East Coast13 Nov 2017
4th Biosimilars North America15 Nov 2017
Lyophilization USA16 Nov 2017
2nd International Conference and Exhibition on Polymer Chemistry27 Nov 2017
Global Medicinal Chemistry & GPCR Leaders Summit27 Nov 2017
Ophthalmic Drugs Conference28 Nov 2017
Digital Pathology Congress30 Nov 2017
Microfluidics Congress: Europe4 Dec 2017
Synthetic Biology & Gene Editing Congress4 Dec 2017
NGS Tech & Applications Congress: Europe4 Dec 2017
qPCR & Digital PCR Congress: Europe4 Dec 2017
12th Annual Cold Chain Distribution13 Dec 2017
Pre-Filled Syringes Europe17 Jan 2018

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement